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ABSTRACT 
Introduction/Purpose To investigate whether a) lower levels of daily physical activity (PA) 
and greater sedentary time accounted for contrasting metabolic phenotypes (higher liver 
fat/presence of metabolic syndrome [MetS+] vs lower liver fat/absence of metabolic syndrome 
[MetS-]) in individuals of similar BMI and b) the association of sedentary time on metabolic 
health and liver fat. 
Methods Ninety-eight habitually active participants (53 female, 45 male; age 39±13 years; 
BMI 26.9±5.1 kg/m2), underwent assessments of PA (SenseWear armband; wear time ~98%), 
cardio-respiratory fitness (V̇O2 peak), body composition (MRI and MRS) and multi-organ 
insulin sensitivity (OGTT). We undertook a) cross-sectional analysis comparing four groups: 
non-obese or obese, with and without metabolic syndrome (MetS+ vs MetS-) and b) univariate 
and multivariate regression for sedentary time and other levels of PA in relation to liver fat. 
Results Light, moderate and vigorous PA did not account for differences in metabolic health 
between individuals, whether non-obese or obese, although MetS+ individuals were more 
sedentary, with a higher number, and prolonged bouts (~1-2 hours). Overall, sedentary time, 
average daily METS and V̇O2 peak were each independently associated with liver fat 
percentage. Each additional hour of daily sedentary time was associated with a 1.15% (95% 
CI, 1.14–1.50%) higher liver fat content. 
Conclusions Greater sedentary time, independent of other levels of PA, is associated with 
being metabolically unhealthy; even in habitually active people, lesser sedentary time, and 
higher cardio-respiratory fitness and average daily METS is associated with lower liver fat.
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INTRODUCTION  1 
Strong epidemiologic evidence suggests an inverse relationship between physical activity (PA) 2 
levels and obesity, metabolic syndrome (MetS), non-alcoholic fatty liver disease (NAFLD) and 3 
type 2 diabetes (1-5). Increased PA is recommended both for individuals and at a population 4 
level to improve metabolic health and help prevent these interrelated conditions. The 5 
independent protective effect of high cardio-respiratory fitness (CRF), an objective marker of 6 
PA, against all-cause mortality is well established (6, 7). There is a growing recognition that 7 
sedentary behaviour, which has an independent association with adverse health outcomes, 8 
should be minimised (2, 8, 9). Increasing moderate PA is protective against the aforementioned 9 
diseases and attenuates, but does not eliminate, the detrimental effects of sedentary behaviour 10 
(10). Breaking up prolonged periods of sedentary time (11) or replacing it with low-intensity 11 
PA (12) are beneficial for glycaemic control. 12 
Obesity is strongly associated with poor cardio-metabolic health and overall mortality (13). 13 
However, not all obese individuals are metabolically unhealthy (MetS+) (14); conversely not 14 
all non-obese individuals are metabolically healthy (MetS-) (15). Some studies suggest that 15 
MetS+ may be a consequence of low PA (16, 17), but others have not supported this conclusion 16 
(18-20). With differences in methodology, cohort characteristics and definitions of metabolic 17 
phenotypes, these studies typically have not precisely defined the differences in PA 18 
characteristics between phenotypes. Only one study, of older adults, has objectively measured 19 
sedentary behaviour (19), which offers better reliability than self-report (21); no such study has 20 
been undertaken in young-middle aged adults. There are similarly conflicting results in studies 21 
of the association of metabolic health with objectively measured sedentary behaviour and 22 
quantitative measures of liver fat using magnetic resonance spectroscopy (MRS) or computed 23 
tomography (CT) (22-26). The accumulation of liver fat has been described as a major 24 
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contributor to the development of  type 2 diabetes (27), is considered the hepatic manifestation 25 
of MetS and closely linked with obesity and insulin resistance (28). Observing levels of PA, 26 
including sedentary behaviour,  in metabolic phenotypes of a given BMI category with further 27 
quantification of liver fat may reveal associations which link habitual activity to health 28 
outcomes and the predisposition for metabolic diseases.  29 
This cross-sectional study will objectively monitor the  habitual PA of young-middle aged 30 
adults and extensively phenotype these individuals by assessment of metabolic health and 31 
MRI-derived body composition. We hypothesise that, greater sedentary time and lower levels 32 
of PA will be evident in metabolically unhealthy phenotypes (MetS+ vs MetS-) in BMI-33 
matched individuals; and secondly, higher MRS-quantified liver fat will be associated with 34 
greater sedentary time and lower PA levels.  35 
METHODS 36 
Participants  37 
Habitually active individuals who engaged in no more than 2 hours of exercise per week, were 38 
recruited via local advertisements across University of Liverpool campuses and hospital 39 
departments. Exclusions included cardiovascular, respiratory, kidney, liver and/or endocrine 40 
complications, smoking and >14 units/week of alcohol consumption. The study conformed to 41 
the Declaration of Helsinki and was approved by the North West Liverpool Central research 42 
ethics committee (14/NW/1145; 14/NW/1147; 15/NW/0550). All participants were informed 43 
of the methods verbally and in writing before providing written informed consent prior to any 44 
assessments. Ninety-eight individuals (52 male, 46 female) with a mean age of 39±13 years 45 
and BMI 27±5 kg/m2 were recruited. Prior to each study visit, participants were required to 46 
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fast overnight for 12 hours (water was permitted ad libitum), abstain from alcohol and caffeine 47 
for 24 hours and from exercise for 48 hours. 48 
Study design  49 
All participants completed measurement of baseline PA and dietary consumption over a period 50 
of 4 days (including one weekend day) between January 2016 and Febuary 2017 followed by 51 
assessment in the the order of a) anthropometry (including bio-impedance), fasting 52 
biochemistry, an oral glucose tolerance test (OGTT) and assessment of CRF (V̇O2 peak) at 53 
University Hospital Aintree and b) magnetic resonance imaging (MRI) and proton magnetic 54 
resonance spectroscopy (1H-MRS) at the University of Liverpool MRI Centre (LiMRiC). Due 55 
to MRI scanner replacement during part of this study, MRI quantification of body fat was 56 
conducted in only 72 individuals. Bio-impedance data was collected in all individuals, and V̇O2 57 
peak calculations were based on both total body mass and fat free mass (FFM).  58 
Individual phenotyping  59 
Individuals were characterised into one of four groups based on BMI (non-obese <30 vs obese 60 
≥30 kg/m2) and the presence or absence of MetS according to International Diabetes Federation 61 
(IDF) criteria; we refer to these groups as i) ‘non-obese MetS-’, ii) ‘non-obese MetS+’, iii) 62 
‘obese MetS-’ and iv) ‘obese MetS+’.  63 
Habitual assessment 64 
Physical activity monitoring PA was monitored throughout using a validated (29) SenseWear 65 
mini armband (BodyMedia Inc., Pittsburgh, PA, USA). Wear time (recorded as ~98%) was 66 
monitored using SenseWear Professional software (version 8.0). Data included: daily average 67 
step count, total energy expenditure, active energy expenditure and time spent in levels of PA 68 
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including: sleep, lying down, sedentary (<1.5 METS), light (1.5-3 METS), moderate (3-6 69 
METS), vigorous (6-9 METS) and very vigorous (>9 METS). A Microsoft Excel template, as 70 
previously described (30), was used to determine how sedentary time (not including sleep) was 71 
accumulated and provided information on the frequency of bouts and the time accumulated in 72 
a given bout category (<1 h: 1–5, 6–10, 11–20, 21–40, 41-60 min; 1-2 h: 61-80, 81-100, 101-73 
120 min; >2 h: 121-140, 141-160, 161-180 min). To examine ‘frequently broken’ periods of 74 
sedentary time, the given bout categories at the lower end (<1 h) were shorter in duration. At 75 
the higher end (> 1h), where fewer bouts are recorded, the given bout categories are greater in 76 
duration. Based on previous observations (31), this approach was adopted to investigate 77 
‘patterns’ of sedentary time, i.e. the frequency with which sedentary time is interrupted 78 
(sedentary breaks) or the duration of uninterrupted periods of sedentary time (sedentary bouts).  79 
Furthermore, moderate-vigorous PA (MVPA) of bouts greater or less than 10 minutes were 80 
determined.    81 
Dietary analysis Total energy consumption, carbohydrate, protein and fat content were 82 
determined from 4-day dietary records by a registered nutritionist (KM) using Nutritics 83 
(Nutrition Analysis Software for Professionals; https://www.nutritics.com/p/home). 84 
Other assessment measures 85 
Anthropometric measurements Stature (Model 220, Seca, Germany) and whole-body bio-86 
impedance analysis (Tanita, BC 420, Dolby Medical Stirling, UK) was conducted; this 87 
provided total body mass, fat percentage, fat mass, fat free mass, muscle mass, total body water, 88 
basal metabolic rate, bone mass and visceral fat indicator. Waist and hip circumference 89 
measurements were taken in duplicate and blood pressure was determined from an average of 90 
three measures (Dinamap, G & E Medical, USA). 91 
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Biochemical measurements Blood samples were collected and analysed using the Olympus 92 
AU2700 analyser (Beckman Coulter, High Wycombe, UK) with standard proprietary reagents 93 
as follows: glucose with hexokinase, total cholesterol and HDL with cholesterol 94 
esterase/oxidase and triacylglycerol with glycerol kinase. LDL was calculated according to the 95 
Friedwald formula. Insulin was measured using radio-immunoassay (Invitrogen, UK). HOMA-96 
IR was calculated using fasting glucose and insulin concentrations.  97 
OGTT Following a 12hr fast, blood samples were collected, a 75 g glucose drink was consumed 98 
within 5 min and post-ingestion blood samples were drawn at 30, 60, 90 and 120 min. Matsuda 99 
index was calculated to estimate whole body IS, and indices of hepatic-IR and skeletal muscle 100 
IS were determined as previously described (32). 101 
CRF A V̇O2 peak cardio-pulmonary exercise test (CPET) was performed on a treadmill (Model 102 
77OCE, RAM Medisoft Group, Manchester, UK) in a temperature-controlled room. The CPET 103 
provided breath-by-breath monitoring and analysis of expiratory gases and ventilation (Love 104 
Medical Cardiopulmonary Diagnostics, Manchester, UK). The modified Bruce protocol was 105 
employed, after an initial 2 min warm up at 2.2 km/h on a flat gradient, step-wise increments 106 
in speed and gradient were employed each minute. V̇O2 peak was determined by exhaustion 107 
plus one or more of: respiratory exchange ratio >1.15, heart rate >90% predicted maximum, 108 
plateau in V̇O2.  109 
1H-MRS Liver and skeletal muscle fat were determined using a 1.5 T Siemens Symphony MRI 110 
scanner as previously described (33).  111 
Statistical analysis  112 
All data were explored for normality using visual inspection of frequency distribution, and 113 
logarithmically transformed where appropriate. Given the small sample size, power achieved 114 
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on each test was assessed and ranged from 46 to >99%; 20 of 26 achieved at least 80% power.  115 
Age was analysed using a one factor between-groups ANOVA whereby a significant group 116 
effect was observed (P<0.05). Between-group univariate general linear models (GLM) were 117 
conducted for all other variables, with age as a covariate and Bonferroni correction for multiple 118 
comparisons. Statistically significant interactions were explored and nominal P-values 119 
reported. Univariate and multivariate linear regression were used to analyse components of PA 120 
and fitness associated with liver fat. Decisions were made a priori to include all variables 121 
reaching P<0.1 in univariate regression analysis alongside age and BMI in the multivariate 122 
regression model. The statistical cut-off for inclusion in the final model is more stringent than 123 
often used to guard against false discovery. The alpha level of statistical significance was set 124 
at P<0.05. Data are presented as mean (95% CI), unless stated otherwise. Transformed data 125 
were back-transformed to original units. P value >1 rounded to 1.000. 126 
RESULTS 127 
Participant characteristics 128 
The numbers of individuals with each risk factor of MetS are summarised in Table 1, with the 129 
PA and CRF data of the whole cohort combined. Calculated from their average of 4 d MVPA 130 
(accumulated in bouts of >10 min), 61% of individuals met the World Health Organisation 131 
(WHO) recommendations. 132 
Metabolic phenotyping  133 
The significant differences between the groups’ components of MetS were in line with IDF 134 
classification (Table 2).  There was no significant difference between obese MetS- and obese 135 
MetS+ BMI (P=0.712) but non-obese MetS+ BMI was 3±2 kg/m2 greater than non-obese 136 
MetS- (P=0.003). In the general population, MRS defined liver fat >5.5% corresponds with 137 
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the prevalence of hepatic steatosis (34); 84 and 14 participants had liver fat <5.5% and ≥5.5% 138 
respectively.  139 
Dietary intake  140 
Total energy consumption, carbohydrate, protein and fat did not differ significantly between 141 
groups (P>0.05). Mean ±SD macronutrient percentages were 56±16% carbohydrate, 24±9% 142 
protein, and 20±7% fat.  143 
CRF  144 
Obese MetS+ individuals had lower CRF than both obese and non-obese MetS- (P≤0.029; 145 
mean difference ≥7.5 mL·min-1·kg-1) but not non-obese MetS+ (P=0.675; mean difference 5.9 146 
mL·min-1·kg-1) There was no difference between both non-obese groups and obese MetS- 147 
(P≥0.080) (Fig. 1a).  148 
Multi-organ IS  149 
Non-obese MetS- individuals had greater Matsuda index than non-obese MetS+ (P=0.012; 150 
mean difference 2.0) (Fig. 1b); there was no difference between obese MetS- and both MetS+ 151 
groups (P≥0.141). There was no group effect for skeletal muscle IS index (P=0.220). Hepatic-152 
IR index was greater in obese MetS+ than non-obese MetS- (Fig. 1c). There was a significant 153 
group effect (P=0.022) for HOMA-IR.  154 
MRS quantification of liver fat  155 
Liver fat was higher in MetS+ in both non-obese and obese. Non-obese MetS- individuals had 156 
4.6% lower liver fat than obese MetS+ (P≤0.005) (Fig. 1d). Liver fat percentage in non-obese 157 
MetS+ was not different to either obese group (P≥0.794; mean difference ≥0.6 %); and liver 158 
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fat percentage in obese groups was not statistically different (P=0.336; mean difference 2.6 159 
%).  160 
Levels of physical activity: differences between the 4 metabolic phenotypes 161 
Average daily steps: There was no group effect for average daily steps (Fig. 2a).  162 
Non-sleep sedentary time, lying time and sleep duration: Non-sleep sedentary time (Fig. 2b) 163 
was not different between non-obese groups (P=1.000; 49 min/day) and obese groups 164 
(P=1.000; 23 min/day). Non-obese MetS- individuals had lower sedentary time than obese 165 
MetS+ (P=0.04); there was no difference between obese MetS- and both MetS+ groups 166 
(P≥0.199). There was no group effect for amount of time spent lying down (P=0.080) or 167 
sleeping (P=0.117).  168 
Daily light PA time: There was no difference in daily light activity between both non-obese 169 
groups (P=0.711; mean difference 10 min/day) and both obese groups (P=1.000; 9 min/day). 170 
However, both obese groups had less light activity than both non-obese MetS- (P≤0.015; mean 171 
difference ≥69 min/day) (Fig. 2c).   172 
Daily moderate-vigorous PA time: There was no difference between the groups’ moderate-173 
vigorous activity (P=0.322) (Fig. 2d) and no significant differences were found for the way in 174 
which MVPA was accumulated for bouts of 10 minutes or more, in either total minutes 175 
accumulated or percentage of the time in relation to total MVPA.  176 
Average daily METS and PA duration: Daily average METS (Fig. 2e) and PA duration (Fig. 177 
2f) had significant group effects (P<0.0005 and P=0.020, respectively); for both measures, 178 
non-obese MetS- had greater values than both obese groups, but were not different to non-179 
obese MetS+. Daily average METS in non-obese MetS- were 0.3 METS greater than both 180 
obese groups (P<0.0005). The same was observed for PA duration, with non-obese MetS- 181 
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having greater duration that both obese groups (P≤0.018; mean difference ≥107 min/day). 182 
There was no significant difference between obese MetS- and both MetS+ groups for average 183 
daily METS and PA duration (P≥0.079 and P≥0.450 respectively).  184 
Patterns of waking sedentary time: Analysis of sedentary behaviour was performed on waking 185 
sedentary time examining the duration of sedentary time (Fig. 3a) and the number of sedentary 186 
bouts (Fig. 3b) in a pre-determined bout category. There were no differences between the 187 
groups in sedentary bout durations of < 1 h or > 2 h. However, significant differences were 188 
apparent during bout durations lasting between 1 and 2 h. Duration: during bouts of 61-80 min, 189 
non-obese MetS+ accumulated 33 min more sedentary time per day than non-obese MetS- (3, 190 
60; P=0.013). During bouts of 81-100 min, MetS+ obese accumulated 34 min per day more 191 
than obese MetS- (6, 62; P=0.018). During bouts of 101-120 min, obese MetS+ accumulated 192 
28 min per day more than obese MetS- (5, 51; P=0.018). Number of bouts: as an average of 4 193 
days, both MetS+ groups accumulated 1-2 more long bouts (between 1-2 h) of sedentary 194 
behaviour, compared to their MetS- counterparts. Considering bouts of 61-80 min, non-obese 195 
MetS+ had 0.5 more bouts per day (0.1, 0.9; P=0.012) than MetS-. Obese MetS+ had 0.4 more 196 
bouts per day (0.1, 0.7; P=0.019) than MetS- of 81-100 min and 0.3 more bouts per day (0.1, 197 
0.5; P=0.017) of 101-120 min.  198 
Levels of physical activity (regression analysis): Univariable linear regression analysis 199 
revealed that daily average steps, sedentary time, vigorous activity, METS and V̇O2 peak were 200 
all significantly associated with liver fat. Carried forward in the multivariable analysis, three 201 
of these factors remained statistically significant predictors of liver fat (Table 3). Greater daily 202 
sedentary time is associated with higher liver fat, while higher overall daily METS and V̇O2 203 
peak are associated with lower liver fat (Fig. 3). For a one hour increase in sedentary time, liver 204 
fat increased by 1.15% (1.14–1.50%; P=0.036) while for a 1 mL·min-1·kg-1 increase in CRF 205 
(V̇O 2 peak), liver fat reduced by 0.87% (0.25, 1.50; P=0.007). 206 
13 
DISCUSSION  207 
The results of this extensive phenotypic analysis of objective measurements of PA and 208 
sedentary behaviour, metabolic and body composition measurements (including MRS-derived 209 
liver fat) in young-middle aged adults demonstrate two key messages. Firstly, in this cohort, 210 
overall habitual PA was not associated with different metabolic health status in individuals of 211 
similar BMI, and the accumulation of sedentary time was weakly associated with the presence 212 
of the MetS. Secondly, even in habitually active individuals, there is an association between 213 
greater sedentary time and increased liver fat, while the amount of moderate-vigorous PA 214 
(MVPA) appeared to have little independent association. These data highlight the potential 215 
importance of sedentary behaviour in determining optimal metabolic health and liver fat.  216 
It is recognised that greater sedentary time increases the risk of becoming overweight/obese 217 
(35) and the risk of type 2 diabetes and cardiovascular disease, even after controlling for MVPA 218 
(8, 36). Whilst total volumes of habitual PA do not explain metabolic health in this cohort, 219 
those with MetS shown some evidence of being more sedentary, with a higher number of 220 
prolonged bouts of sedentary behaviour (between 1-2 hours). Frequent breaks in sedentary time 221 
have been shown to be beneficial to metabolic risk (31), health (37) and liver fat (24).  To our 222 
knowledge, there are no studies which have investigated sedentary bouts greater than 1 hour. 223 
Interestingly, an extra hour of sedentary time has been associated with a 39% increased odds 224 
for MetS (38) and decreasing sedentary time accumulated in prolonged bouts may have 225 
beneficial effects om BMI and waist circumference (39). Futher research at durations of >1 226 
hour may reveal insight into the the pattern in which sedentary time is accumulated and MetS. 227 
Even individuals who are physically active can still spent a significant amount of their waking 228 
day sedentary, (termed previously sedentary exercisers’ (40)) which is associated with 229 
increased cardio-metabolic risk. Taken together, these findings suggest that public health and 230 
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chronic disease prevention strategies that largely focus on MVPA recommendations, might 231 
benefit from new recommendations regarding interruption of prolonged sedentary time, 232 
complimentary to those of PA. 233 
Numerous prospective studies have confirmed the relationship between PA and liver fat (5, 41-234 
44) and compliance with national MVPA guidelines has been associated with a lower odds of 235 
NAFLD (26). Furthermore, recent research in a population-based sample of adults has shown 236 
that V̇O2 peak is strongly, inversely and independently related to the risk of liver fat (45). The 237 
results presented are in agreement with previous research, greater levels of PA (here daily 238 
METs) and higher CRF is independently associated with lower levels of liver fat. Importantly, 239 
the associations between CRF and liver fat remained after adjustment for BMI; not all studies 240 
have reported similar findings (46). The association between sedentary time and liver fat is 241 
equivocal.  Some authors have found no associations between PA or sedentary behaviour and 242 
liver fat in 82 individuals (25, 26). Whereas others have concluded that PA and sedentary time 243 
are indeed independently associated with the prevalence of NAFLD (22, 24). In inactive 244 
individuals every hour of sedentary time was associated with increases of 1.74 L of total 245 
abdominal fat, 0.62 L of visceral fat, 1.14 L of subcutaneous fat, and 1.86% liver fat (22). 246 
Direct comparisons or broad conclusions are difficult due to differences in cohorts and 247 
methodology. The findings of the current study suggest that sedentary time has an independent 248 
effect on liver fat in active adults, however more data is required to confirm this. Our results 249 
demonstrating that every hour of additional sedentary time translates to a 1.15% increase in 250 
liver fat, can be put into context by comparing the effects of a 4 week aerobic cycling 251 
intervention in sedentary obese men and women, where liver fat reduced by 1.7% (47).  The 252 
effects surgical, nutritional, lifestyle or pharmaceutical interventions aiming to reduce liver fat 253 
has been recently reviewed (48).  254 
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This study utilises objective monitoring of PA, gold standard measurement of CRF and MRS-255 
derived liver fat in young-middle aged adults, all of which are key strengths. The results did 256 
not support any strong evidence for a beneficial association of sedentary bouts <1 hour or 257 
detrimental association of >2 hours perhaps due to study limitations which include the 258 
relatively small sample size. Further limitations include: duration of PA assessment, the 259 
monitor used to assess sedentary behaviour (SenseWear does not determine postural 260 
differences), the comparatively healthy habitual PA habits of the participants which somewhat 261 
limits the external validity of the findings, and the cross-sectional design which cannot 262 
determine causality. Noteworthy is the higher BMI in unhealthy non-obese versus healthy non-263 
obese which confirms to the association of a greater BMI with greater metabolic risk. This 264 
difference could not be controlled for as it was a component of our grouping analysis but 265 
differences in age were statistically controlled for. While the present results demonstrate that 266 
overall sedentary time needs to be considered independently of PA, objective PA monitoring 267 
in a larger cohort with a prospective design will be required and future research should further 268 
explore sedentary behaviour patterns (i.e. amount of sedentary breaks and duration of sedentary 269 
bouts). The American Diabetes Association has recommended that adults should ‘decrease the 270 
amount of time spent daily in sedentary behaviour’ and that ‘prolonged sitting should be 271 
interrupted with bouts of light activity every 30 min’. Importantly, these recommendations are 272 
in addition to, not a substitute for, a physically active lifestyle. A ‘cut-off’ for harmful sedentary 273 
behaviour patterns (i.e. frequency/duration) has not been defined in public health guidelines. 274 
In summary, in habitually active adults, the amount of sedentary time is associated in this 275 
single-measure observation with metabolic health and the quantity of liver fat. The findings of 276 
this study highlight that public health policy designed to optimise the benefits of physical 277 
activity may need to synergistically consider strategies to reduce sedentary behaviour. 278 
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Figure 1 Cardio-metabolic phenotyping, individual participant plots for: V̇O2 peak relative to 
fat free mass (FFM) (a), whole body insulin sensitivity (b), hepatic insulin resistance index (c) 
and liver intrahepatocellular lipid (IHCL) (d). Data are presented as mean ± SD. Grey circles, 
MetS-; white circles, MetS+; non-obese are grouped left and obese are grouped right. *P<0.05 
group difference between BMI category, further group differences being given in the text. 
Figure 2 Habitual physical activity and sedentary time, individual participant plots for: average 
daily steps (a), non-sleep sedentary time (<1.5 METS) (b), light activity (1.5−3 METS) (c), 
moderate-vigorous activity (>3 METS) (d), daily metabolic equivalents (METS) (e) and 
physical activity (PA) duration (f). Data are presented as mean ± SD. Grey circles, MetS-; 
white circles, MetS+; non-obese are grouped left and obese are grouped right. *P<0.05 group 
difference between BMI category, further group differences being given in the text. 
Figure 3 Non-sleep sedentary behaviour, individual participant plots for: duration of sedentary 
bouts (a) and number of sedentary bouts in given bout category (b) between 1-2 h. Data are 
presented as mean ± SD. Grey circles, MetS-; white circles, MetS+; non-obese are grouped left 
and obese are grouped right. *P<0.05 group difference between BMI category, further group 
differences being given in the text. 
 
 
